You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HHT

Showing 1 - 25 of 117
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Telangiectasia, Hereditary Hemorrhagic, Intracranial Arteriovenous Malformations Trial in Odense (Brain MRI)

Recruiting
  • Telangiectasia, Hereditary Hemorrhagic
  • Intracranial Arteriovenous Malformations
  • Brain MRI
  • Odense, Fyn, Denmark
    Danish HHT-center. Odense University Hospital
Jul 6, 2023

Patients With HHT. Follow up BABH

Completed
  • Hemorrhagic Hereditary Telangiectasia
  • HHT
  • bevacizumab treatment
  • Angers, France
  • +2 more
Sep 8, 2023

Hereditary Hemorrhagic Telangiectasia (HHT) Trial in Worldwide (VAD044)

Recruiting
  • Hereditary Hemorrhagic Telangiectasia (HHT)
  • Boston, Massachusetts
  • +5 more
Dec 14, 2022

Healthy Trial in Wuxi (HHT120, Placebo)

Withdrawn
  • Healthy
  • Wuxi, Jiangsu, China
    Affiliated Hospital of Jiangnan University
Jan 30, 2023

Hereditary Hemorrhagic Telangiectasia, HHT, Rendu Osler Weber Disease Trial in Madrid (Registry)

Recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • +2 more
  • Registry
  • Madrid, Spain
    Hospital Universitario Ramón y Cajal
Sep 30, 2022

Nationwide Awareness Campaign and Call for Dental Screening for

Active, not recruiting
  • Hereditary Hemorrhagic Telangiectasia
  • Dental Diseases
    • Marburg, Germany
      University Hospital Marburg
    Mar 21, 2022

    Telangiectasia, Hereditary Hemorrhagic Trial in Lausanne (Nintedanib, Placebo)

    Recruiting
    • Telangiectasia, Hereditary Hemorrhagic
    • Lausanne, Vaud, Switzerland
      Respiratory medicine Department, Lausanne University Hospital
    Jul 22, 2022

    Hereditary Hemorrhagic Telangiectasia, Epistaxis, Anemia Trial (Pazopanib, Placebo oral capsule)

    Not yet recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • +4 more
    • (no location specified)
    Aug 17, 2022

    Hereditary Hemorrhagic Telangiectasia

    Completed
    • Hereditary Haemorrhagic Telangiectasia (HHT)
    • questionnaire
    • Essen, Germany
      University Hospital Essen
    Mar 21, 2022

    Hereditary Hemorrhagic Telangiectasia, HHT, Arteriovenous Malformation of Brain Trial in Toronto (Registry and Saliva sample)

    Recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • +2 more
    • Registry and Saliva sample
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Nov 19, 2021

    Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed Trial in Toronto (Tacrolimus capsule (low-dose))

    Recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • Epistaxis Nosebleed
    • Tacrolimus capsule (low-dose)
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Feb 15, 2022

    Video-assisted Instructions of Nasal Self-packing in HHT

    Recruiting
    • Hereditary Haemorrhagic Telangiectasia
    • video-assisted nasal self-packing
    • Essen, Nordrhein Westphalen, Germany
      University Hospital Essen
    Mar 21, 2022

    Acute Myeloid Leukemia Trial in NanJing (Homoharringtonine, Azacitidine)

    Recruiting
    • Acute Myeloid Leukemia
    • NanJing, China
      Department of Hematology, Zhongda Hospital, Medical School of So
    Sep 2, 2022

    Acute Myeloid Leukemia Trial in Suzhou (Venetoclax, Homoharringtonine, Cytarabine)

    Recruiting
    • Acute Myeloid Leukemia
    • Suzhou, Jiangsu, China
      Qiu Huiying
    Mar 28, 2023

    HHT, Hereditary Hemorrhagic Telangiectasia, Epistaxis Trial in Stanford (Bevacizumab, Placebo (Saline))

    Completed
    Has Results
    • HHT
    • +4 more
    • Stanford, California
      Stanford University Department of Otolaryngology- Head and Neck
    Aug 6, 2021

    Ultra-low-dose Chest CT for HHT

    Active, not recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • Ultra-low dose chest CT
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    May 25, 2022

    Hereditary Hemorrhagic Telangiectasia Trial in Essen (hypoxic induced factors)

    Recruiting
    • Hereditary Hemorrhagic Telangiectasia
    • hypoxic induced factors
    • Essen, NRW, Germany
      University Hospital Essen
    Mar 21, 2022

    Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease Trial in France (Nintedanib 150 mg and 100 mg soft capsules, Oral

    Recruiting
    • Telangiectasia, Hereditary Hemorrhagic
    • Rendu Osler Disease
    • Nintedanib 150 mg and 100 mg soft capsules
    • Oral treatment of placebo soft capsule
    • Angers, France
    • +9 more
    Mar 16, 2022

    Rendu Osler Disease, Telangiectasia, Hereditary Hemorrhagic Trial in France (Bevacizumab, sodium chloride 0.9%)

    Completed
    • Rendu Osler Disease
    • Telangiectasia, Hereditary Hemorrhagic
    • Angers, France
    • +3 more
    Oct 14, 2021

    Telangiectasia, Hereditary Hemorrhagic, Osler Rendu Disease Trial in Bron (Timolol nasal spray, Placebo nasal spray)

    Completed
    • Telangiectasia, Hereditary Hemorrhagic
    • Osler Rendu Disease
    • Timolol nasal spray
    • Placebo nasal spray
    • Bron, France
      Hospices Civils de Lyon - Hôpital Femme Mère Enfant / Service de
    Oct 14, 2021

    Hereditary Hemorrhagic Telangiectasia Trial in Toronto (Topical timolol maleate, saline drops)

    Completed
    • Hereditary Hemorrhagic Telangiectasia
    • Topical timolol maleate
    • placebo saline drops
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Nov 19, 2021

    Telangiectasia, Hereditary Hemorrhagic, Rendu Osler Disease Trial in Bron (Low CT scanner without injection dose, Ultra-low dose

    Completed
    • Telangiectasia, Hereditary Hemorrhagic
    • Rendu Osler Disease
    • Low CT scanner without injection dose
    • Ultra-low dose CT scanner without injection
    • Bron, France
      Hospices Civils de Lyon - Hopital Louis Pradel
    Oct 14, 2021

    Relapsed or Refractory Acute Myeloid Leukemia Trial in Taiyuan (Selinexor, Homoharringtonine, Daunorubicin)

    Recruiting
    • Relapsed or Refractory Acute Myeloid Leukemia
    • Taiyuan, Shanxi, China
      Tao Wang
    Feb 9, 2023

    Hereditary Hemorrhagic Telangiectasia (HHT) Trial in Toronto (Doxycycline Hyclate, Placebo)

    Active, not recruiting
    • Hereditary Hemorrhagic Telangiectasia (HHT)
    • Doxycycline Hyclate
    • Placebo
    • Toronto, Ontario, Canada
      St. Michael's Hospital
    Feb 8, 2022

    Relapsed/Refractory Acute Myeloid Leukaemia, Myeloid Malignancy Trial in China (APG-2575, reduced-dose HHT, standard-dose HHT)

    Recruiting
    • Relapsed/Refractory Acute Myeloid Leukaemia
    • Myeloid Malignancy
    • Beijing, Beijing, China
    • +9 more
    Jan 10, 2022